These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 38787060)

  • 1. Specificity of DNA ADP-Ribosylation Reversal by NADARs.
    Cihlova B; Lu Y; Mikoč A; Schuller M; Ahel I
    Toxins (Basel); 2024 Apr; 16(5):. PubMed ID: 38787060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis for the reversible ADP-ribosylation of guanosine bases.
    Schuller M; Raggiaschi R; Mikolcevic P; Rack JGM; Ariza A; Zhang Y; Ledermann R; Tang C; Mikoc A; Ahel I
    Mol Cell; 2023 Jul; 83(13):2303-2315.e6. PubMed ID: 37390817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis for DarT ADP-ribosylation of a DNA base.
    Schuller M; Butler RE; Ariza A; Tromans-Coia C; Jankevicius G; Claridge TDW; Kendall SL; Goh S; Stewart GR; Ahel I
    Nature; 2021 Aug; 596(7873):597-602. PubMed ID: 34408320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA ADP-Ribosylation Stalls Replication and Is Reversed by RecF-Mediated Homologous Recombination and Nucleotide Excision Repair.
    Lawarée E; Jankevicius G; Cooper C; Ahel I; Uphoff S; Tang CM
    Cell Rep; 2020 Feb; 30(5):1373-1384.e4. PubMed ID: 32023456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Toxin-Antitoxin System DarTG Catalyzes Reversible ADP-Ribosylation of DNA.
    Jankevicius G; Ariza A; Ahel M; Ahel I
    Mol Cell; 2016 Dec; 64(6):1109-1116. PubMed ID: 27939941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Back to the Roots: Deep View into the Evolutionary History of ADP-Ribosylation Opened by the DNA-Targeting Toxin-Antitoxin Module DarTG.
    Harms A; Gerdes K
    Mol Cell; 2016 Dec; 64(6):1020-1021. PubMed ID: 27984742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TARG1 protects against toxic DNA ADP-ribosylation.
    Tromans-Coia C; Sanchi A; Moeller GK; Timinszky G; Lopes M; Ahel I
    Nucleic Acids Res; 2021 Oct; 49(18):10477-10492. PubMed ID: 34508355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel components of NAD-utilizing metabolic pathways and prediction of their biochemical functions.
    de Souza RF; Aravind L
    Mol Biosyst; 2012 Jun; 8(6):1661-77. PubMed ID: 22399070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of cholera toxin and Escherichia coli heat-labile enterotoxins by ADP-ribosylation factors, a family of 20 kDa guanine nucleotide-binding proteins.
    Moss J; Vaughan M
    Mol Microbiol; 1991 Nov; 5(11):2621-7. PubMed ID: 1779753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADP-ribosylation of DNA and RNA.
    Groslambert J; Prokhorova E; Ahel I
    DNA Repair (Amst); 2021 Sep; 105():103144. PubMed ID: 34116477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrolysis of ADP-Ribosylation by Macrodomains.
    Posavec Marjanovic M; Jankevicius G; Ahel I
    Methods Mol Biol; 2018; 1813():215-223. PubMed ID: 30097870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of site-directed mutagenesis of Escherichia coli heat-labile enterotoxin on ADP-ribosyltransferase activity and interaction with ADP-ribosylation factors.
    Stevens LA; Moss J; Vaughan M; Pizza M; Rappuoli R
    Infect Immun; 1999 Jan; 67(1):259-65. PubMed ID: 9864224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global Analysis of the Specificities and Targets of Endoribonucleases from Escherichia coli Toxin-Antitoxin Systems.
    Culviner PH; Nocedal I; Fortune SM; Laub MT
    mBio; 2021 Oct; 12(5):e0201221. PubMed ID: 34544284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of Escherichia coli heat-labile enterotoxins by native and recombinant adenosine diphosphate-ribosylation factors, 20-kD guanine nucleotide-binding proteins.
    Lee CM; Chang PP; Tsai SC; Adamik R; Price SR; Kunz BC; Moss J; Twiddy EM; Holmes RK
    J Clin Invest; 1991 May; 87(5):1780-6. PubMed ID: 1902492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The DarT/DarG Toxin-Antitoxin ADP-Ribosylation System as a Novel Target for a Rational Design of Innovative Antimicrobial Strategies.
    Catara G; Caggiano R; Palazzo L
    Pathogens; 2023 Feb; 12(2):. PubMed ID: 36839512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The DarTG toxin-antitoxin system provides phage defence by ADP-ribosylating viral DNA.
    LeRoux M; Srikant S; Teodoro GIC; Zhang T; Littlehale ML; Doron S; Badiee M; Leung AKL; Sorek R; Laub MT
    Nat Microbiol; 2022 Jul; 7(7):1028-1040. PubMed ID: 35725776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible mono-ADP-ribosylation of DNA breaks.
    Munnur D; Ahel I
    FEBS J; 2017 Dec; 284(23):4002-4016. PubMed ID: 29054115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADP-ribosylation of RNA and DNA: from in vitro characterization to in vivo function.
    Weixler L; Schäringer K; Momoh J; Lüscher B; Feijs KLH; Žaja R
    Nucleic Acids Res; 2021 Apr; 49(7):3634-3650. PubMed ID: 33693930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The natural history of ADP-ribosyltransferases and the ADP-ribosylation system.
    Aravind L; Zhang D; de Souza RF; Anand S; Iyer LM
    Curr Top Microbiol Immunol; 2015; 384():3-32. PubMed ID: 25027823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADP-Ribosylation, a Multifaceted Posttranslational Modification Involved in the Control of Cell Physiology in Health and Disease.
    Lüscher B; Bütepage M; Eckei L; Krieg S; Verheugd P; Shilton BH
    Chem Rev; 2018 Feb; 118(3):1092-1136. PubMed ID: 29172462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.